| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9227072 | Journal of Allergy and Clinical Immunology | 2005 | 6 Pages |
Abstract
A significant reduction in IOP occurred with nasal steroid discontinuation in patients with glaucoma. Nasal steroids might contribute to IOP increase, and inquiry as to whether a patient has glaucoma before medication initiation is warranted.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Christina M. MD, Heidi PhD, Yu PhD, Karen M. MD, PhD,